{
    "root": "315b8a94-b7cd-1b47-e063-6294a90a2d39",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Enalapril Maleate",
    "value": "20250327",
    "ingredients": [
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "SODIUM BICARBONATE",
            "code": "8MDF5V39QO"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "ENALAPRIL MALEATE",
            "code": "9O25354EPJ"
        }
    ],
    "indications": null,
    "contraindications": null,
    "warningsAndPrecautions": "enalapril maleate tablets , usp ndc number strength quantity description 68071-3820-3 20 mg bottles 30 child-resistant closure ( desiccant ) yellow , round scored tablet , debossed “ 11 ” scored one side , “ 11 ” one side score plain side . storage store 20 oto 25 oc ( 68 oto 77 ) ; excursions permitted 15° 30°c ( 59° 86°f ) [ usp controlled room temperature ] . keep container tightly closed . protect moisture . dispense tight container per usp , product package subdivided . manufactured : zhejiang huahai pharmaceutical co. , ltd. xunqiao , linhai , zhejiang 317024 , china distributed : solco healthcare us , llc somerset , nj 08873 , usa revised : 03/2022 203419-01",
    "adverseReactions": "enalapril maleate tablets contraindicated patients hypersensitive product patients history angioedema related previous treatment angiotensin-converting enzyme inhibitor patients hereditary idiopathic angioedema . coadminister aliskiren enalapril maleate tablets patients diabetes ( , ) . enalapril maleate tablets contraindicated combination neprilysin inhibitor ( e.g . , sacubitril ) . administer enalapril maleate tablets within 36 hours switching sacubitril/valsartan , neprilysin inhibitor ( , head neck angioedema ) .",
    "warningsAndPrecautions_original": "Enalapril Maleate Tablets, USP\n                              \n                           \n                        \n                        \n                           \n                              \n                                 NDC Number\n                              \n                           \n                           \n                              \n                                 Strength\n                              \n                           \n                           \n                              \n                                 Quantity\n                              \n                           \n                           \n                              \n                                 Description\n                              \n                           \n                        \n                        \n                           \n                              68071-3820-3\n                              \n                           \n                           20 mg\n                           \n                              Bottles of 30 with child-resistant closure\n                              (with desiccant)\n                           \n                           Yellow, round scored tablet, debossed with “S 11” and scored on one side, “S 11” is on one side of the score and plain on the other side.\n                        \n                        \n                           \n                           \n                              \n                           \n                           \n                              \n                           \n                           \n                              \n                           \n                        \n                        \n                           \n                              \n                           \n                           \n                        \n                        \n                           \n                              \n                           \n                           \n                              \n                           \n                        \n                        \n                           \n                              \n                           \n                           \n                        \n                     \n                  \n                  \n                     Storage\n                  \n                  Store at 20 \n  oto 25 \n  oC (68 \n  oto 77 \n  oF); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].\n \n                  Keep container tightly closed.\n                  Protect from moisture.\n                  Dispense in a tight container as per USP, if product package is subdivided.\n                  \n                     Manufactured by:\n                  \n                  Zhejiang Huahai Pharmaceutical Co., Ltd.\n                  Xunqiao, Linhai, Zhejiang 317024, China\n                  \n                     Distributed by:\n                  \n                  Solco Healthcare US, LLC\n                  Somerset, NJ 08873, USA\n                  Revised: 03/2022\n                  203419-01",
    "adverseReactions_original": "Enalapril maleate tablets are contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an angiotensin-converting enzyme inhibitor and in patients with hereditary or idiopathic angioedema.\n                  Do not coadminister aliskiren with enalapril maleate tablets in patients with diabetes (see\n \n  \n                        PRECAUTIONS, Drug Interactions\n                     ).\n\n \n                  Enalapril maleate tablets are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer enalapril maleate tablets within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor (see\n \n  \n                        WARNINGS, Head and Neck Angioedema\n                     )."
}